Log In
Print this Print this

Hepatitis E vaccine (HEV 239)

  Manage Alerts
Collapse Summary General Information
Company Xiamen Innovax Biotech Co. Ltd.
DescriptionRecombinant hepatitis E antigen adsorbed to aluminum hydroxide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis E virus (HEV)
Indication DetailsVaccinate against hepatitis E virus (HEV) infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today